Imidapril hydrochloride

This classification denotes an ace inhibitor with the molecular formula C20H27N3O6.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7NSF9GG1NU, chemically known as 4-imidazolidinecarboxylic acid, 3-((2s)-2-(((1s)-1-(ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)-1-methyl-2-oxo-, monohydrochloride, (4s)- but more generally known as imidapril hydrochloride, which bears US NIH Compound Identifier 5485193. European Medicines Agency schedules Imidapril hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02642MIG. Most nations, for tariff and trade purposes, schedule imidapril hydrochloride under HS 29332990 and SITC 51573. As of Q4 2014, IMIDAPRIL HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Imidapril hydrochloride bears US NLM identifiers UMLS ID C0872994 and NCI Concept Code C99550. SMILES: CCOC(=O)[C@H](CCC1CCCCC1)N[C@@H](C)C(=O)N2[C@@H](CN(C2=O)C)C(=O)O.CL.